Increasing tacrolimus time‐in‐therapeutic range is associated with superior one‐year outcomes in lung transplant recipients - Ensor, Christopher R.; Iasella, Carlo J.; Harrigan, Kate M.; Morrell, Matthew R.; Moore, Cody A.; Shigemura, Norihisa; Zeevi, Adriana; McDyer, John F.; Venkataramanan, Raman (American journal of transplantation, 2018)
Keywords: Adult; Aged; bronchiolitis obliterans (BOS); Calcineurin; Calcineurin inhibitors; Chronic infection; clinical research/practice; Cross-Sectional Studies; Female; Graft rejection; health services and outcomes research; Humans; immunosuppressant ‐ calcineurin inhibitor: tacrolimus; immunosuppression/immune modulation; Immunosuppressive agents; Immunosuppressive Agents - therapeutic use; immunosuppressive regimens – maintenance; lung (allograft) function/dysfunction; Lung Transplantation; lung transplantation/pulmonology; Lung transplants; Male; Middle Aged; Mortality; rejection: acute; Tacrolimus; Tacrolimus - therapeutic use; Therapeutic drug monitoring; Treatment Outcome; Xenografts; lung (allograft) function/dysfunction; bronchiolitis obliterans (BOS); rejection: acute; immunosuppression/immune modulation; clinical research/practice; lung transplantation/pulmonology; immunosuppressive regimens - maintenance; immunosuppressant - calcineurin inhibitor: tacrolimus; health services and outcomes research